Table 1.
Baseline characteristics of 153 patients with wearable cardioverter defibrillator (WCD).
| Variables | (n = 153) |
|---|---|
| Demographics | |
| Age, mean ± SD *(years) | 60 ± 14 |
| Female, n (%) | 35 (23) |
| Indication for WCD use, n (%) | |
| Myocarditis | 8 (5) |
| ICD */CRT-D * Explant | 16 (10) |
| ICM *, LVEF * < 35% | 56 (37) |
| NICM *, LVEF < 35% | 70 (46) |
| Congenital diseases | 3 (2) |
| Clinic parameter | |
| Cadiogenic shock at event, n (%) | 13 (8) |
| Pulmonary edema, n (%) | 14 (9) |
| Days of hospitalization, mean ± SD | 15.8 ± 11.9 |
| Former significant VT */VF * prior to WCD use, n (%) | 26 (17) |
| Medical history, n (%) | |
| Former CIED explanted | 7 (5) |
| History of CAD * | 61 (40) |
| History of myocardial infarction | 48 (31) |
| History of CABG * | 11 (7) |
| Moderately severe CKD/Dialysis * | 20 (13) |
| History of CHF * | 23 (15) |
| History of Atrial fibrillation/flutter | 37 (24) |
| History of TIA/stroke * | 9 (6) |
| Cardiovascular Risk Factors, n (%) | |
| Smoking | 67 (44) |
| Diabetes mellitus | 31 (20) |
| Overweight (BMI > 25 kg/m2) * | 106 (69) |
| Lipidemia | 67 (44) |
| Hypertension | 87 (57) |
| COPD * | 16 (11) |
| Family history of cardiovascular disease | 42 (28) |
* SD: Standard deviation; ICD: implantable cardioverter defibrillator; CRT: cardiac resynchronization therapy; LVEF: Left ventricular ejection fraction; ICM: ischemic cardiomyopathy; NICM: non-ischemic cardiomyopathy; VT: ventricular tachycardia; VF: ventricular fibrillation; CAD: coronary artery disease; CABG: coronary artery bypass graft; CKD: chronic kidney disease; CHF: congestive heart failure; TIA: transient ischemic attack; BMI: body-mass-index; COPD: chronic obstructive pulmonary disease; CIED: cardiovascular implantable electronic device.